| | | |  | As doctors and researchers return to ASCO after a pandemic-era pause, STAT reporters will sit down with newsmakers driving science and cancer policy and dig in to what we expect to learn over the four-day meeting. Grab your ticket for the Friday, June 3, event here. | | | | By Tara Bannow and Bob Herman Adobe Even as some proton therapy centers falter, some big-name hospitals are setting up the facilities to attract cancer patients. Read More | | By Eric Boodman Adobe "We wanted to make a vaccine that could be more generally used in large patient populations,” said the senior author of the new paper. Read More | | By Adam Feuerstein Andy Wong/AP New data could both help and hinder the biotech’s efforts to stand apart from a rival Amgen treatment approved one year ago. Read More | | Sponsor content by Nektar Therapeutics The Promise of IL-15 to Potentiate CAR T-cell Therapy While chimeric antigen receptor (CAR) T-cell therapy is a revolutionary new therapeutic breakthrough in cancer treatment that has been shown to achieve complete or partial remission in patients with hematologic malignancies, durability of response remains a challenge. Discover how NKTR-255 may be able to leverage the power of IL-15 to improve CAR-T cell persistence to provide an innovative new treatment option to cancer patients. | | By Sylvie Leotin Adobe To uproot health inequities in the U.S. for centuries, it is essential to understand the experiences of underserved and marginalized people. Read More | | By Adam Feuerstein and Meg Tirrell This week, we're joined by physician and parent Jeremy Faust to discuss his take on the Covid vaccine data for children under 5. Read More | | By Nicholas St. Fleur Keisha Okafor for STAT What happens when AI and medical algorithms replicate the biases and blind spots of the humans who create them? Read More | |
No comments